Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (WHO grade III and IV).

This medicinal product should only be used by experienced neurosurgeons conversant with surgery of malignant gliomas and in-depth knowledge of functional brain anatomy who have completed a training course in fluorescence-guided surgery.

The recommended dose is 20 mg 5-ALA HCl per kilogram body weight.

Patients with renal or hepatic impairment

No trials have been performed in patients with clinically relevant hepatic or renal impairment.

Therefore, this medicinal product should be used with caution in such patients.

Get “SPC Gliolan 02-2014.pdf”…

Download the Gliolan SPC.